 Pittsburgh, Pennsylvania -- Medical device company ALung Technologies has garnered $10 million in a series B round of venture capital investment.
ALung is developing gas exchange devices for the treatment of acute and chronic respiratory disorders.
Eagle Ventures and Birchmere Ventures made the investment, along with other undisclosed investors.
The company said it would use the funding to support the continued commercialization of its Hemolung Respiratory Assist System |